MIM
INVE icon

MetLife Investment Management’s Identive INVE Stock Holding History

MetLife Investment Management’s Portfolio INVE Stock Details INVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,766
Closed -$35.4K – 2967
2023
Q1 		$35.4K Sell
5,766
-6,118
-51% -$45K ﹤0.01% 2741
2022
Q4 		$86K Hold
11,884
– – ﹤0.01% 2649
2022
Q3 		$149K Hold
11,884
– – ﹤0.01% 2463
2022
Q2 		$138K Hold
11,884
– – ﹤0.01% 2548
2022
Q1 		$192K Buy
11,884
+4,167
+54% +$80K ﹤0.01% 2374
2021
Q4 		$217K Hold
7,717
– – ﹤0.01% 2002
2021
Q3 		$145K Hold
7,717
– – ﹤0.01% 2266
2021
Q2 		$131K Buy
+7,717
New +$117K ﹤0.01% 2374

Other funds holding INVE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MetLife Investment Management's INVE Position: Q2 2023 in Review

MetLife Investment Management sold out of Identive (INVE) in Q2 2023, closing a stake of 5,766 shares — an estimated $35.4K sold.

MetLife Investment Management first reported a position in INVE in Q2 2021 and held it in 8 quarters. The position peaked at $217K in Q4 2021. 74 funds tracked by Wall St. Rank hold INVE as of Q2 2023.

  • MetLife Investment Management reported no remaining Identive position as of Q2 2023 after selling out during the quarter.
  • MetLife Investment Management sold 5,766 Identive shares in Q2 2023, an estimated $35.4K.
  • MetLife Investment Management first reported a position in Identive in Q2 2021 and held it in 8 quarters.
  • MetLife Investment Management's Identive position peaked at $217K in Q4 2021.
  • 74 funds tracked by Wall St. Rank held Identive as of Q2 2023.

Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.